In addition, the authors reported good AUROC values of GP73 for predicting significant (0.89) and severe (0.93) fibrosis and cirrhosis (0.96) [48], for the identification of MASH (0.83) patients [46], and to identify severe (0.89) and moderate (0.74) inflammatory activity in MASH patients [47]. Here, GOLM1 is linked to metabolic dysfunction-associated steatohepatitis.